Cancer Genetics Inc (NASDAQ:CGIX)

Data as of --
-- -- / --
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-8.4M-19.9M-6.7M-12.4M
Total Other Cash Flow3.2M13.0M-973.8K5.8M
Funds From Operations-4.9M-6.5M-7.3M-6.3M
Funds From/For Other Operating Expenses834.2K-1.4M291.8K1.8M
Net Cash Flow - Operating Activities-5.7M-5.1M-7.6M-8.1M
InvestingOther Investing - Uses0.000.00-50.0K-50.0K
Other Investing - Sources11.6K238.4K0.00--
Net Cash Flow Investing-168.0K-113.1K-347.8K-1.4M
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing7.6M5.8M6.3M58.1M
Exchange RateEffect of Exchange Rate on Cash------0.00--
Net Change In Cash1.7M638.0K-1.6M48.6M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.